Aarti Pharmalabs faces ₹59.5 crore stamp duty penalty over demerger

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Aarti Pharmalabs received a ₹59.50 crore penalty order from Gujarat Stamp Authority
  • The levy includes ₹25 crore in stamp duty and ₹34.50 crore in penalties
  • The dispute concerns stamp duty on the 2022 demerger scheme with Aarti Industries
  • The company plans to challenge the order citing strong legal grounds
powered bylight_fuzz_icon
49913602

*this image is generated using AI for illustrative purposes only.

Aarti Pharmalabs has received a penalty order of ₹59.50 crore from the Gujarat Stamp Authority regarding unpaid stamp duty on its demerger scheme. The company intends to challenge the decision.

The Office of the Superintendent of Stamps, Gandhinagar, issued the order on August 29, 2026, under Chapter IV of the Gujarat Stamp Act, 1958. It pertains to the Scheme of Arrangement between Aarti Industries Limited and Aarti Pharmalabs Limited, which was sanctioned by the NCLT, Ahmedabad Bench, on September 21, 2022.

Penalty Breakdown

The total liability comprises stamp duty and penalties levied for alleged short payment or non-payment of duty. The components are detailed below:

Component Amount
Stamp Duty ₹25 crore
Penalty (deficient duty) ₹25 crore
Additional Penalty ₹9.50 crore
Total ₹59.50 crore

The stamp duty was calculated under Article 20(D) of Schedule-I of the Gujarat Stamp Act. The first penalty component equals the deficient duty amount as per Rule 9 of the Mumbai Stamp (Market Value Determination) Rules, 1984. The additional penalty was imposed under the Gujarat Stamp Act, 1958.

Company Response

Aarti Pharmalabs disclosed the receipt of the order on September 1, 2026, while awaiting the physical copy dispatched via registered post. The company stated it is evaluating the order and believes it has a strong case on merits.

Management indicated it will challenge the order, citing adequate factual and legal grounds to substantiate its position. The disclosure was made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Historical Stock Returns for Aarti Pharma Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+0.24%+3.87%+29.99%+19.84%+0.76%0.0%

How might the legal challenge against the ₹59.50 crore penalty impact Aarti Pharmalabs' short-term cash flow and liquidity ratios?

Could this dispute with the Gujarat Stamp Authority set a precedent for other companies involved in similar demerger schemes under the Gujarat Stamp Act?

What is the potential timeline for the resolution of this case, and how might prolonged litigation affect investor sentiment and stock volatility?

Aarti Pharmalabs schedules 7th AGM for September 22, 2026

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • 7th AGM scheduled for September 22, 2026, via video conferencing
  • Remote e-voting open from September 19 to September 21, 2026
  • Dividend record date set for September 15, 2026
  • Final dividend payment due by October 20, 2026
powered bylight_fuzz_icon
49620716

*this image is generated using AI for illustrative purposes only.

Aarti Pharmalabs Limited will hold its 7th Annual General Meeting on Tuesday, September 22, 2026. The meeting is scheduled for 11:00 am and will be conducted through video conferencing or other audio-visual means.

The company dispatched the AGM notice and annual report for FY26 via email on August 29, 2026. Shareholders holding shares as of the cut-off date of Tuesday, September 15, 2026, are eligible to vote.

E-Voting Details

Members can cast their votes electronically using the facility provided by National Securities Depository Limited. The remote e-voting period begins on Saturday, September 19, 2026, at 9:00 am and ends on Monday, September 21, 2026, at 5:00 pm.

Once a vote is cast, it cannot be changed. Members who vote remotely can still attend the meeting but cannot vote again. Those who do not vote remotely can cast their votes during the meeting.

Dividend Record Date

The record date for determining dividend entitlement for FY26 is Tuesday, September 15, 2026. The final dividend payment will be made on or before Tuesday, October 20, 2026, subject to shareholder approval at the AGM.

What the Numbers Show

The company has aligned its dividend record date with the e-voting cut-off date of September 15, 2026. This synchronization ensures that shareholders eligible to participate in corporate governance decisions are also entitled to the final dividend payout for the fiscal year.

Historical Stock Returns for Aarti Pharma Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+0.24%+3.87%+29.99%+19.84%+0.76%0.0%

What specific dividend per share amount is Aarti Pharmalabs proposing for FY26, and how does it compare to the previous fiscal year?

Are there any special resolutions or significant corporate governance changes, such as board appointments or policy amendments, on the AGM agenda?

How might the outcome of the shareholder vote impact Aarti Pharmalabs' capital allocation strategy for the upcoming fiscal year?

More News on Aarti Pharma Labs

1 Year Returns:+0.76%